Virginia Bio’s Post

We have a NEW research study for you to consider participating in. Check it out along with other active trials here: https://ow.ly/KsS950RxG2r. And new industry news—check that out as well: https://ow.ly/ORMB50RxG2s. PLEASE NOTE: Narcolepsy Network does not endorse, advise, recruit, or promote participation in any specific clinical trial or study. #NarcolepsyNetwork #narcolepsy #idiopathichypersomnia #sleepdisorder #invisibleillness #raredisease

Great article about how AFib still needs more exposure in society, and the debilitating effects it can cause. Also, am I the only one that still misses Mike & Mike in the morning? #Bringitback #EPeeps #AFib #Electrophysiology

𝐖𝐞 𝐚𝐥𝐥 𝐥𝐨𝐯𝐞 𝐁𝐢𝐫𝐭𝐡𝐝𝐚𝐲𝐬, 𝐝𝐨𝐧’𝐭 𝐰𝐞?  But, have you ever wondered, when was the first clinical trial “born”? James Lind often receives credit for being the author of the first clinical trial in May 1747. However, the roots of clinical research stretch even further back in time⌛ Beginning with this intriguing question, we are excited to announce our new rubric – “𝐂𝐥𝐢𝐧𝐢𝐜𝐚𝐥 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐔𝐧𝐛𝐨𝐱𝐞𝐝”🎉 At MONIPOL, we believe the Clinical Research industry is very interesting: from impacting patient health to navigating regulatory frameworks, it's a field where every day brings new challenges and opportunities for growth. That's why we're committed to helping individuals learn more about these topics, raising awareness, and enhancing the overall understanding of the clinical research industry in the public eye. Follow us for more #insightful content 🚀  #ClinicalResearch #ClinicalTrials #CRO 

#NEW VIDEO RESOURCE - Understanding what research is available for young people and families impacted by Huntington’s disease can be overwhelming and confusing. Participating in research is also a very personal decision. This video will provide information about what types of research are available to people in the HD community, and how you may access those opportunities. We hope you find this video helpful and informative as you contemplate participating in research. To view additional videos about clinical trials and what participating in an observational study is like, visit the HDYO Breaking Down Barriers YouTube Channel. Additional research opportunities and updates are available at HDYO.org.    Breaking Down Barriers is sponsored by Teva Pharmaceuticals, uniQure, Griffin Foundation, Roche Sage Therapeutics and Neurocrine Biosciences. **Multiple languages will be offered on YouTube playlist via closed captioning. #huntingtonsdisease #research #chdi #hdbuzz #hope #hdyo #raredisease #letstalkabouthd https://lnkd.in/gWP-Mhkh

Looking to achieve non-dilutive funding for your R&D? In the United States there are many sources of non-dilutive funding from both public and private institutions and organizations including: -The National Institutes of Health -Defense Advanced Research Projects Agency (DARPA) -Defense Threat Reduction Agency -Biomedical Advanced Research and Development Authority (BARDA) -THE MICHAEL J FOX FOUNDATION FOR PARKINSON -Bill & Melinda Gates Foundation and more. And they don’t cover just one area of research. Funding is provided across all the sectors of the life sciences to ensur the development of diagnostic tools, treatments, medical devices, and more. We want to make sure you have a deeper understand of the funding that is available to you, so speak to one of our non-dilutive funding experts and let us guide you on your journey toward achieving non-dilutive funding. Start your non-dilutive funding journey > https://lnkd.in/dEGv96bG More information about the various funding sources > https://lnkd.in/d46jmEk9 #ResearchandDevelopment #Funding #LifeSciences #Grants #GrantWriting 

Did you know? Jarosław Kasprowicz, PhD, MBA, Head of Clinical Operations at Clinmark, who will be representing us at the upcoming Bio Convention in San Diego, boasts over 12 years of extensive expertise in clinical trials setup, monitoring, and management across diverse therapeutic fields. With his wealth of experience, he's ready to explore collaborations and discuss how Clinmark can elevate your research. Don't miss this opportunity to connect and schedule a meeting with him! #Clinmark #BioConvention #SanDiego #ClinicalResearch #CebioForum #PolishTradeandInvestmentAgncy

POTENTIAL NEW TREATMENT FOR NO-OPTION CLI PATIENTS The Flowox device from Otivio AS might provide an alternative to amputation for CLI patients with no options. The impact on the microcirculation is particularly intriguing. New treatments are needed for CLI, which is increasing in prevalence due to the aging population and the epidemic of diabetes. I believe the Flowox device is approved for sale in the EU but do not know the current approval status in the U.S. #CLI #CLTI #amputationprevention #amputationlottery #clifighters

The Cochrane Collaboration is an international charity which synthesizes medical research findings to facilitate evidence-based choices about health interventions involving health professionals, patients and policy makers. They are currently developing a new scientific strategy and want feedback from the public. There's more detail below from Cochrane - if you'd like to give some feedback here's a link to more information and a survey: https://lnkd.in/gF9wqsJW For the uninitiated, Cochrane calls the public (you) 'consumers' - which means 'everyone'. (I'm sharing this as I volunteer as a member of the Cochrane Consumer Executive - you can learn more about what we do here: https://lnkd.in/gMJBN9bW ) Here's a bit more from Cochrane about the scientific strategy: The Cochrane Collaboration is developing a Scientific Strategy to set out how we will achieve our mission by producing evidence that benefits global health over the next five years. The Scientific Strategy will direct our limited resources to the world’s most critical health needs. It is also an opportunity to raise Cochrane’s profile – helping shape the research agenda for global health and attract new funders and collaborators. Developing the Scientific Strategy provides Cochrane with an important opportunity to engage with consumers to understand their priorities and how they want us to address them. The Scientific Strategy will also align closely with our Organisational Strategy, which sets out how we will deliver our research and supporting activities in a way that maximises the benefits for consumers. The Organisational Strategy sets out ambitions for increasing our breadth and depth of consumer engagement. We have done initial work with our research community to map areas of global health need and draw up proposals for the areas we should prioritise in our Scientific Strategy. We are now keen to gain the views of Cochrane’s Consumer Network.

Celebrating Clinical Trials Day with Catalyst. Every Trial Matters, Every Life Counts. #ClinicalResearch, #catalystclinicalresearch, #ConnectWithCatalyst Catalyst Clinical Research

ChemDiv Presented Non-Clinical Summary Data for The Best-in-Class Selective FLT3 Clinical Candidate at the 65th ASH Annual Meeting and Exposition with Its Partners and Sponsors. https://lnkd.in/ezfYg-Jf #Non_Clinical_Summary_Data